Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06201624
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2023-12-30
Brief Title:
Oral Isotretinoin in Melasma a Randomized Controlled Trial
Sponsor:
Zagazig University
Organization:
Zagazig University
Study Overview
Official Title:
Oral Isotretinoin in The Treatment of Melasma A Randomized Controlled Clinical Trial
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Melasma is a common refractory acquired hyperpigmentation of the skin having a serious impact on patients quality of life Melasma is challenging to treat Treatment is often a multimodality approach Due to the attached psychological and social stress it is important to counsel patients with melasma adequately about the chronicity of the disease the importance of photoprotection and the role of hormones in disease persistence before embarking on therapeutic correction So in this study we are exploring the efficacy of oral isotretinoin for treating melasma
Detailed Description:
Melasma has a significant impact on the quality of life and self-esteem of those affected Darker skin photo types eg Egyptians have excess potential to develop melasma
Melasma is a chronic and challenging condition to manage Previous treatment modalities have been unsatisfactory
Oral isotretinoin is a potential treatment modality for melasma that has not been investigated yet
In this study we aim to evaluate the efficacy and the tolerability of oral isotretinoin in the treatment of melasma and to compare its efficacy and tolerability with the current gold standard topical triple combination formula
Melasma is a chronic and challenging condition to manage Previous treatment modalities have been unsatisfactory
Oral isotretinoin is a potential treatment modality for melasma that has not been investigated yet
In this study we aim to evaluate the efficacy and the tolerability of oral isotretinoin in the treatment of melasma and to compare its efficacy and tolerability with the current gold standard topical triple combination formula
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None